Healthtech sits at the intersection of digital technology and clinical practice. The Global Talent application for a healthtech founder requires specific evidence architecture — here is how to structure it.
Healthtech founders occupy an interesting position for Global Talent applications. On one hand, the sector's regulatory complexity, the clinical stakes, and the institutional dynamics make genuine innovation particularly meaningful — if you've changed how something works in healthcare technology, the impact is real and often documentable. On the other hand, the evidence types available to healthtech founders are specific to the sector and require careful framing.
The most credible innovation claims in healthtech are:
Clinical workflow transformation. If your technology changed how clinical staff work — reducing administrative burden, improving information access, accelerating decision support — and you can document the change in clinical behaviour and its outcomes, that is sector-level innovation.
Data infrastructure for health systems. Building interoperability, data pipelines, or analytics infrastructure that NHS trusts or health systems depend on is a significant contribution. The NHS is one of the most data-rich and data-complex organisations in the world; making it work better is genuinely exceptional work.
Patient-facing digital health. Applications that demonstrably changed patient behaviour or outcomes — not just digital versions of existing services, but new capabilities — with documented evidence are strong innovation claims.
Regulatory science innovation. If your work contributed to developing the regulatory framework for digital health in the UK — engagement with MHRA, NHS Digital (now NHS England Digital), NICE, or CQC on how digital health tools should be evaluated — that is a sector-level contribution of a specific type that assessors from the health tech world will recognise.
Working with the NHS — whether through direct contracts, NIHR funding, NHS SBRI grants, or partnerships with specific trusts — provides a specific type of external validation. The NHS has rigorous procurement and evaluation processes. Being selected as a supplier or partner requires passing a technical and clinical assessment.
Evidence from NHS relationships:
NICE's evidence assessments are particularly strong because they are independent, rigorous, and publicly documented. If your product has been through any form of NICE assessment process, that documentation is strong external validation.
Many healthtech founders have a clinical background (medicine, nursing, pharmacy) rather than a technical background. The Global Talent visa is for the digital technology sector, which means the evidence needs to be framed around your digital technology innovation rather than your clinical expertise.
The connection: your clinical expertise enabled you to identify a problem and design a solution that engineers without clinical knowledge couldn't have built. Your specific contribution — the insight, the product design, the clinical validation methodology — is where the innovation lives.
A letter from a clinical co-founder, clinical advisor, or senior NHS clinical leader who explains why your specific background was essential to solving the problem in a way that delivers genuine clinical value can bridge this framing.
Healthtech has specific funding validation signals that carry credibility in this sector:
These funding signals are different from general VC funding — they represent government and NHS assessments of clinical value and technological merit, not just commercial potential.
Building in healthtech and wondering whether your profile qualifies for Global Talent? The free readiness assessment evaluates health-tech specific evidence patterns and shows you exactly where you stand.
Ready to find out where you stand?
See your Founder Credibility Index score and exactly which dimensions to fix first.